StockData

Frazier Life Sciences Acquisition Corp. II (FLSC) stock

FLSCNasdaqBlank ChecksFiscal year ends December 31
Last filing: 10-Q on Nov 17, 2026
$10.07−0.03 (-0.25%)

Close on Nov 17, 2026Market cap –P/E –Yield –

Earnings

Frazier Life Sciences Acquisition Corp. II's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Frazier Life Sciences Acquisition Corp. II's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Frazier Life Sciences Acquisition Corp. II has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Frazier Life Sciences Acquisition Corp. II puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Frazier Life Sciences Acquisition Corp. II filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News

See a number that looks wrong?